secwatch.observer — SEC 8-K summary
======================================

Issuer:     iRhythm Holdings, Inc. (IRTC)
CIK:        0001388658
Form:       8-K
Filed at:   2023-05-04T23:59:59+00:00
Accession:  0001388658-23-000048
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

iRhythm reports Q1 revenue $111.4M (+20.6% YoY); updates FY2023 guidance to $480-$490M
--------------------------------------------------------------------------------

- Revenue $111.4M (+20.6% YoY); gross margin 67.9%, up 100 bps from 66.9%.
- Net loss $39.1M ($1.29 loss per share) vs $50.6M ($1.71 loss per share) in Q1 2022.
- Adjusted net loss $33.4M ($1.10 loss per share) vs $23.7M ($0.80 loss per share) in Q1 2022.
- FY2023 revenue guidance raised to $480-$490M (17%-19% growth); gross margin 69%-70% expected.
- CAMELOT study at ACC.23/WCC showed Zio XT highest diagnostic yield, lowest retesting rates.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1388658/000138865823000048/0001388658-23-000048-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1388658/000138865823000048/irtc-20230504.htm
  HTML page:      https://secwatch.observer/filing/0001388658-23-000048

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer